McKesson (NYSE:MCK) Releases FY 2026 Earnings Guidance

Posted by Jeff Wilder on Feb 4th, 2026

McKesson (NYSE:MCK – Get Free Report) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 38.800-39.200 for the period, compared to the consensus estimate of 38.660. The company issued revenue guidance of -.

Analysts Set New Price Targets

MCK has been the topic of a number of analyst reports. Barclays assumed coverage on shares of McKesson in a research report on Monday, December 8th. They set an “overweight” rating and a $960.00 target price on the stock. Robert W. Baird set a $968.00 price objective on McKesson in a report on Wednesday, January 14th. Weiss Ratings reiterated a “buy (a-)” rating on shares of McKesson in a research report on Monday, December 29th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of McKesson in a research report on Wednesday, December 10th. Finally, Jefferies Financial Group boosted their price target on McKesson from $820.00 to $900.00 and gave the company a “buy” rating in a research note on Monday, October 13th. Two research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $899.36.

Read Our Latest Report on MCK

McKesson Price Performance

Shares of MCK stock traded down $31.54 on Wednesday, hitting $819.58. 1,707,572 shares of the company’s stock were exchanged, compared to its average volume of 644,754. The company has a 50 day moving average of $826.85 and a 200 day moving average of $776.36. The stock has a market cap of $101.16 billion, a P/E ratio of 25.51, a price-to-earnings-growth ratio of 1.39 and a beta of 0.40. McKesson has a 12 month low of $570.51 and a 12 month high of $895.58.

McKesson (NYSE:MCK – Get Free Report) last posted its earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.04% and a negative return on equity of 248.14%. The firm had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Sell-side analysts predict that McKesson will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be paid a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson’s payout ratio is presently 10.21%.

Insider Buying and Selling at McKesson

In related news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the business’s stock in a transaction on Friday, November 7th. The stock was sold at an average price of $861.63, for a total transaction of $283,476.27. Following the sale, the chief accounting officer owned 328 shares in the company, valued at $282,614.64. The trade was a 50.08% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Thomas L. Rodgers sold 276 shares of the company’s stock in a transaction dated Monday, January 5th. The stock was sold at an average price of $816.18, for a total value of $225,265.68. Following the completion of the transaction, the executive vice president directly owned 2,268 shares of the company’s stock, valued at approximately $1,851,096.24. The trade was a 10.85% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.08% of the stock is currently owned by corporate insiders.

More McKesson News

Here are the key news stories impacting McKesson this week:

Positive Sentiment: Q3 results showed strong profit growth and an EPS beat — diluted EPS $9.59 (+38% YoY) vs. consensus ~$9.31; operating profit and net income both rose materially, and revenue grew ~11% to $106.2B. McKesson (MCK) Releases Q3 2026 Earnings: EPS Beats, Profit Growth but Weak Operating Cash Flow
Positive Sentiment: Company raised FY‑2026 adjusted EPS guidance to $38.800–$39.200, slightly above consensus (~$38.66), signaling management expects continued earnings strength. McKesson Corporation Reports Fiscal 2026 Third Quarter Results and Raises Full Year Adjusted EPS Guidance
Positive Sentiment: Street support remains solid — multiple recent buy/overweight ratings and median analyst target above the current price, which can provide a valuation cushion for holders. McKesson (MCK) Releases Q3 2026 Earnings: EPS Beats, Profit Growth but Weak Operating Cash Flow
Neutral Sentiment: Cash and equivalents increased materially to ~$3.0B YoY, improving near‑term liquidity even as balance sheet dynamics change. McKesson (MCK) Releases Q3 2026 Earnings: EPS Beats, Profit Growth but Weak Operating Cash Flow
Negative Sentiment: Operating cash flow weakened sharply — cash from operations fell ~152% YoY to ~$1.2B, raising questions about the quality/timing of earnings and working capital management. McKesson (MCK) Releases Q3 2026 Earnings: EPS Beats, Profit Growth but Weak Operating Cash Flow
Negative Sentiment: Insider selling activity (including CEO sales) and a rise in total liabilities (~$84.3B, +14% YoY) may amplify short‑term selling pressure. McKesson (MCK) Releases Q3 2026 Earnings: EPS Beats, Profit Growth but Weak Operating Cash Flow
Negative Sentiment: Strategic change — McKesson has fully exited its European business, which could reduce international diversification and create near‑term disruption around the transition. McKesson fully exits European market

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in MCK. Sunbelt Securities Inc. raised its stake in shares of McKesson by 3.6% during the third quarter. Sunbelt Securities Inc. now owns 494 shares of the company’s stock valued at $382,000 after acquiring an additional 17 shares during the last quarter. Morningstar Investment Management LLC grew its stake in shares of McKesson by 2,451.4% in the third quarter. Morningstar Investment Management LLC now owns 15,130 shares of the company’s stock worth $11,689,000 after purchasing an additional 14,537 shares during the last quarter. SHUTTLEWORTH & Co acquired a new stake in McKesson in the third quarter valued at $2,297,000. Armistice Capital LLC bought a new position in McKesson during the 3rd quarter worth $4,522,000. Finally, CANADA LIFE ASSURANCE Co raised its position in McKesson by 0.9% during the 3rd quarter. CANADA LIFE ASSURANCE Co now owns 187,803 shares of the company’s stock worth $143,092,000 after purchasing an additional 1,669 shares during the last quarter. Institutional investors own 85.07% of the company’s stock.

McKesson Company Profile

(Get Free Report)

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.